Insights

Innovative Technology Medincell's proprietary BEPO® technology for long-acting injectables presents a compelling opportunity for firms focused on advanced drug delivery solutions, particularly those seeking to enhance patient compliance and reduce environmental impact.

Strategic Collaborations The company's recent partnerships with industry leaders like AbbVie and Teva indicate a strong pipeline of next-generation therapies, offering potential avenues for joint development, licensing, or pharmaceutical distribution partnerships.

Expanding Market Presence Participation in major global healthcare conferences and the appointment of a Chief Strategy Officer for U.S. operations suggest Medincell is scaling its market outreach, providing opportunities to engage with their expanding healthcare network and distribution channels.

Financial Growth Opportunity With recent funding of $57 million and a revenue range of $1 million to $10 million, Medincell is positioned for growth, making it a viable partner for supply chain solutions, manufacturing services, or investment collaborations.

Focus on Global Health Medincell’s mission to improve global health through accessible and sustainable therapies aligns with the values of organizations aiming to expand innovative healthcare solutions worldwide, presenting potential market expansion and partnership opportunities.

Similar companies to Medincell S.A.

Medincell S.A. Tech Stack

Medincell S.A. uses 8 technology products and services including Jamf, Slick, Lenis, and more. Explore Medincell S.A.'s tech stack below.

Jamf
Enterprise Mobility Management
Slick
Javascript Libraries
Lenis
Javascript Libraries
Modernizr
Javascript Libraries
Priority Hints
Performance
HSTS
Security
Apache
Web Servers
AddToAny
Widgets

Media & News

Medincell S.A.'s Email Address Formats

Medincell S.A. uses at least 1 format(s):

Medincell S.A. Email Formats	Example	Percentage
First.Last@medincell.com	John.Doe@medincell.com	50%
First.Last@medincell.com	John.Doe@medincell.com	50%

Frequently Asked Questions

Where is Medincell S.A.'s headquarters located?

Medincell S.A.'s main headquarters is located at 3 rue des Frères Lumière, Jacou, Occitanie 34830, FR. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is Medincell S.A.'s phone number?

You can contact Medincell S.A.'s main corporate office by phone at

+1-858-216-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Medincell S.A.'s stock symbol?

Medincell S.A. is a publicly traded company; the company's stock symbol is MEDCL.PA.

What is Medincell S.A.'s official website and social media links?

Medincell S.A.'s official website is medincell.com and has social profiles on LinkedIn Crunchbase.

What is Medincell S.A.'s SIC code NAICS code?

Medincell S.A.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Medincell S.A. have currently?

As of October 2025, Medincell S.A. has approximately 164 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Business Officer: S. E.Chief Strategy Officer, U.S. Finance: G. K.Chief Operating Officer: P. M.. Explore Medincell S.A.'s employee directory with LeadIQ.

What industry does Medincell S.A. belong to?

Medincell S.A. operates in the Pharmaceutical Manufacturing industry.

What technology does Medincell S.A. use?

Medincell S.A.'s tech stack includes JamfSlickLenisModernizrPriority HintsHSTSApacheAddToAny.

What is Medincell S.A.'s email format?

Medincell S.A.'s email format typically follows the pattern of First.Last@medincell.com. Find more Medincell S.A. email formats with LeadIQ.

How much funding has Medincell S.A. raised to date?

As of October 2025, Medincell S.A. has raised $57M in funding. .

When was Medincell S.A. founded?

Medincell S.A. was founded in 2002.

Medincell S.A.

Pharmaceutical ManufacturingFrance51-200 Employees

Better Medicine for All

MedinCell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. 
Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. 
We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options.

Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition for achieving our objectives.

#BetterMedicineForAll #ImpactHealth #GlobalHealth #ControlledRelease #CreativeThinking #InnovationForward #Science